Stryker Hip Replacement Lawsuits

Free Case Evaluation

Thousands of people have filed Stryker hip replacement lawsuits for complications and injuries caused by Stryker’s Rejuvenate, ABG II and LFIT Metal V40 Femoral Head hip implants.

Every year in the U.S., over 300,000 hip surgeries are performed to replace worn or damaged hip joints with artificial joint replacement devices. Even though these devices are intended to improve functioning and mobility, many patients who have gotten a Stryker hip implant, are faced with early device failure, resulting in complications and a need for revision surgery.

The Stryker company which manufactures a number of artificial joint replacement products is potentially facing thousands of lawsuits for injuries caused by their devices.

Involved products include:

  • Stryker ABG II System
  • Stryker Rejuvenate System
  • Stryker metal LFIT V40 Femoral Head

Stryker Hip Replacement Complications

Stryker hip replacement products which have caused serious complications in a number of patients are metal-on-metal (MoM) devices which are similar to other devices that have been recalled.

Metal-on-metal devices are constructed of various metal alloys including chromium, cobalt and titanium. Metal surfaces which were intended to be more sturdy and longer-lasting, can create serious problems due to metal fragmentation and shedding that occurs when surfaces grate against one another.

Metal fragmentation and shedding causes complications in the area of the hip device, but also can result in body-wide immune reaction from metal ions which have been absorbed into the bloodstream.

Complications due to Stryker Hip Implants may include:

  • Severe or chronic pain
  • Inflammation
  • Infection
  • Joint dissolution
  • Hip dislocation
  • Implant detachment
  • Flu-like illness

Implant failure due to metallosis or other complications will generally require a hip revision surgery to repair damage, remove failed device and replace it with a new artificial joint. In some cases, multiple surgeries may be required.

Read more about Hip Replacement Complications.

Stryker Hip Lawsuit Settlements

Stryker has faced thousands of lawsuits for complications caused by its hip implant devices. Some of these lawsuits have been settled but others remain in federal, state and local courts.

In 2014, thousands of lawsuits filed for injuries caused by the Stryker Rejuvenate modular-neck stem device were settled for a total of $1 billion. The original settlement offer was later extended and included both the Rejuvenate and ABG-II modular-neck hip stem devices for a total estimated amount of $1.4 billion at a rate of about $300,000 per plaintiff, depending upon individual circumstances. A third settlement period was again extended but Stryker’s problems continued to emerge.

In 2016, the U.S. Food and Drug Administration (FDA) issued a recall of the Stryker metal LFIT V40 femoral head which had also caused an alarming number of serious injuries. The device was withdrawn from the market and has since been the subject of numerous lawsuits which could reach into the thousands.

Stryker LFIT metal V40 femoral-head hip lawsuits filed in federal courts have been consolidated into multidistrict litigation (MDL) in the U.S. District Court for Massachusetts.  MDL groups also exist in several state courts including California and New Jersey but others may also exist in other jurisdictions. No settlements have been announced thus far.

Filing a Stryker Hip Lawsuit

People who have developed complications after receiving a Stryker Hip Implant may be eligible for compensation for medical costs, pain and suffering, lost wages or other issues.

Problems with Stryker metal-on-metal hip implant devices include:

  • Inflammation
  • Hip pain
  • Infection
  • Difficulty walking or standing
  • Inflammation of and soft tissue damage to the area surrounding the implant
  • Loosening of the device with need for repair or replacement

Evaluation of each individual case will be necessary to determine eligibility through a Stryker Hip Replacement lawsuit.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.


Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.